| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |